Selected article for: "acute presentation and magnetic resonance imaging"
Author: Ghodsi, Saeed; Taghi, Sara; Alizadeh-Sani, Zahra; Jenab, Yaser; Hosseini, Zahra; Vaskelyte, Laura
Title: Association of COVID-19 infection with large thrombi in left and right atrial appendages
  • Cord-id: 9qnvq1oj
  • Document date: 2021_9_16
    • ID: 9qnvq1oj
    Snippet: BACKGROUND: Multiple intra-atrial thrombi are found rarely except in the presence of prosthetic valves, intra-cardiac devices, structural connections like foramen ovale and thrombophilia. CASE PRESENTATION: We reported acute thrombosis formation in right and left atrial appendages of a 66-year old man admitted due to progressive dyspnea since 7 days earlier. He had a history of prior laryngeal Squamous Cell Carcinoma, apical hypertrophic cardiomyopathy (HCM), and atrial fibrillation (AF). Infect
    Document: BACKGROUND: Multiple intra-atrial thrombi are found rarely except in the presence of prosthetic valves, intra-cardiac devices, structural connections like foramen ovale and thrombophilia. CASE PRESENTATION: We reported acute thrombosis formation in right and left atrial appendages of a 66-year old man admitted due to progressive dyspnea since 7 days earlier. He had a history of prior laryngeal Squamous Cell Carcinoma, apical hypertrophic cardiomyopathy (HCM), and atrial fibrillation (AF). Infection with COVID-19 was confirmed thereafter. Cardiac Magnetic Resonance Imaging (CMR) suggested the diagnosis of atrial clot superior to neoplasm. After surgical removal of the thrombi, symptoms as well as imaging features of pneumonia were resolved. CONCLUSIONS: We should focus on different presentations and complications of systemic inflammation especially in the setting of COVID-19 infection. Although risk factors of thrombosis are present in some of these patients, rapid progression as well as unusual types of involvement may indicate to a new trigger.

    Search related documents:
    Co phrase search for related documents
    • activate coagulation and lmwh molecular weight heparin: 1
    • activate coagulation and low lmwh molecular weight heparin: 1
    • activator inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • activator inhibitor and lmwh molecular weight heparin: 1
    • activator inhibitor and low lmwh molecular weight heparin: 1
    • acute ards respiratory distress syndrome and adequate anticoagulation: 1
    • acute ards respiratory distress syndrome and admission prior: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and low grade fever: 1, 2, 3
    • acute ards respiratory distress syndrome and low lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute ards respiratory distress syndrome and lung parenchymal involvement: 1
    • acute ards respiratory distress syndrome and lvef ventricular ejection fraction: 1
    • acute ards respiratory distress syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6
    • adequate anticoagulation and lmwh molecular weight heparin: 1, 2, 3
    • adequate anticoagulation and low lmwh molecular weight heparin: 1, 2, 3
    • admission prior and lmwh molecular weight heparin: 1, 2
    • admission prior and low lmwh molecular weight heparin: 1, 2
    • admission prior and lung cancer: 1